Projects per year
Personal profile
Research interests
1. Economic and behavioural evidence of precision medicine, applying cost-effectiveness analysis and stated preference methods. 2. Establishing gene-based precision public health in Australia. 3. Methodologies for the economic evaluation of healthcare technologies.
Fingerprint
Dive into the research topics where Shan Jiang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 1 Active
-
MUAPS Top-Up Scholarship
Cutler, H. (Primary Chief Investigator), Parkinson, B. (Chief Investigator) & Jiang, S. (PhD Student)
14/12/23 → 13/12/26
Project: Research
-
Is best-worst scaling suitable for patient preference elicitation? A nationwide representative comparison with discrete choice experiments among patients with type 2 diabetes in China
Liu, S., Chen, Y., Tao, Y., Lian, D., Jiang, S., Li, S. & Gu, Y., 6 Jan 2026, In: BMJ Public Health. 4, 1, p. 1-10 10 p., e003571.Research output: Contribution to journal › Article › peer-review
Open AccessFile -
Aggregate distributional cost-effectiveness analysis: a novel tool for health economic evaluation to inform resource allocation
Jiang, S., Li, B., Parkinson, B., Li, S. & Gu, Y., 16 Apr 2025, In: Global Health Research and Policy. 10, 1, p. 1-5 5 p., 17.Research output: Contribution to journal › Comment/opinion › peer-review
Open AccessFile1 Citation (Scopus)6 Downloads (Pure) -
Baseline distribution of quality-adjusted life expectancy in Australia: socioeconomic, ethnic, and geographic comparisons
Kalay, A. F., Jiang, S., Gu, Y. & Parkinson, B., 22 Jul 2025, 16th IHEA World Congress on Health Economics - Program Abstract Book. International Health Economics Association, Ind-2454Research output: Chapter in Book/Report/Conference proceeding › Conference abstract
-
Cost-effectiveness of toripalimab plus chemotherapy versus chemotherapy as first-line treatment for advanced non-small cell lung cancer in China: a societal perspective
Lian, D., Gan, Y., Yang, Y., Xiao, D., Xiang, Y., Jiang, S., Gu, Y. & Chen, Y., 2025, In: Expert Review of Pharmacoeconomics and Outcomes Research. 25, 4, p. 587-596 10 p.Research output: Contribution to journal › Article › peer-review
-
Evaluating Cost Effectiveness And Distributional Impact Of Breast Cancer Screening: A Distributional Cost-Effectiveness Analysis Incorporating Patient Preference
Jiang, S., Parkinson, B. & Gu, Y., 1 Dec 2025, In: International Journal of Technology Assessment in Health Care. 41, S1, p. S13-S14 2 p., OP28.Research output: Contribution to journal › Article › peer-review
Open Access
-
Shall We Pay More For Rare Disease Drugs? Assessing Decision-makers’ Preferences By A Sequential Discrete Choice Experiment Approach
Gu, Y. (Speaker), Jiang, S. (Speaker), Li, S. (Speaker) & Wang, H. (Speaker)
16 Jun 2025Activity: Talk or presentation › Presentation
-
Dynamic Distributional Cost Effectiveness Analysis: Tracking Cost-Effectiveness and Health Inequality Over time
Jiang, S. (Speaker), Parkinson, B. (Speaker) & Gu, Y. (Speaker)
2 Dec 2025Activity: Talk or presentation › Presentation
-
Evaluating Cost-Effectiveness And Distributional Impact Of Breast Cancer Screening: A Distributional Cost-Effectiveness Analysis Incorporating Patient Preference
Jiang, S. (Speaker), Parkinson, B. (Speaker) & Gu, Y. (Speaker)
17 Jun 2025Activity: Talk or presentation › Presentation
-
Discrete Choice Experiment: Design and Analysis
Jiang, S. (Speaker)
31 Dec 2024 → 2 Jan 2025Activity: Talk or presentation › Invited talk
-
The Lancet Regional Health - Western Pacific (Journal)
Jiang, S. (Reviewer)
2024 → …Activity: Peer-review and editorial of research outputs › Publication Peer-review